首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1471985

主動脈覆膜支架市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、最終用戶和地理位置

Aortic Stent Grafts Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography

出版日期: 2024年03月07日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄

主動脈覆膜支架市場預計將從2023年的24.9億美元成長到2031年的40.3億美元；預計 2023 年至 2031 年市場複合年成長率為 6.2%。

推動市場成長的關鍵因素是主動脈瘤發生率的增加以及對血管內修復等微創手術的需求不斷成長。然而，市場參與者發起的產品召回阻礙了市場的成長。此外，製造商的技術進步和策略活動預計將在未來幾年帶來新的主動脈覆膜支架市場趨勢。

主動脈覆膜支架市場的市場促進因素與限制

主動脈瘤盛行率的上升促進了主動脈覆膜支架市場的成長。根據愛思唯爾 2021 年 3 月發表的文章，已開發國家有 2% 至 8% 的人患有腹主動脈瘤（AAA）。如果不及時治療，它可能會發展為危及生命的破裂，死亡率高達 80%。主動脈覆膜支架是主動脈瘤血管內修復的重要組成部分。根據英國國家醫療服務體系 (NHS) AAA 篩檢計畫於 2022 年 4 月發布的 2020 年至 2021 年 AAA 標準報告，約 210,800 名男性接受了篩檢，期間發現了 1,542 例動脈瘤病例。在發現動脈瘤的患者中，88.8%的適合擇期修復的患者接受了手術。肥胖、吸菸和久坐的生活方式是這種心血管疾病的危險因子。老年人更容易患心血管疾病，包括主動脈瘤，因此他們經常需要血管內動脈瘤修復（EVAR）手術。主動脈覆膜支架主要用於這些手術，因為與傳統的開放性修復手術相比，它具有減少住院和 ICU 住院時間以及失血量等優點。因此，主動脈瘤手術數量的增加推動了主動脈覆膜支架市場的成長。

然而，主動脈支架移植市場不斷增加的產品召回引起了醫療保健提供者和患者的擔憂。這些召回可能是由於設計缺陷、製造缺陷或安全標準不足造成的。主動脈支架移植市場主要參與者回想的一些產品如下：

2023 年 5 月，Terumo Aortic 主動召回特定批次的 Terumo Aortic TREO 腹部覆膜支架系統，原因是移植物尺寸不正確的潛在問題。

2021 年 2 月，由於支架斷裂和 III 型內漏的風險，美敦力召回了其未使用的 Valiant Navion 胸腔覆膜支架系統。

2020 年 5 月，Endologix Inc. 宣布召回其 Ovation iX 產品，因為植入過程中存在液體聚合物洩漏的風險。該公司表示，大多數聚合物洩漏的根本原因是製造過程中的材料缺陷。

由於產品召回，對某些品牌和產品的信任可能會減弱，從而導致對主動脈瓣置換裝置的需求可能下降。此外，患者和醫療專業人員在考慮這些設備時可能會變得格外謹慎，更願意選擇替代方案或延遲手術。因此，產品召回的增加阻礙了主動脈覆膜支架市場的成長。

主動脈覆膜支架市場：細分概述

主動脈覆膜支架市場根據產品和最終用戶進行細分。依產品分類，市場分為腹主動脈覆膜支架及胸主動脈覆膜支架。 2023年，腹主動脈覆膜支架細分市場將佔據更大的市場佔有率。這種覆膜支架被植入患者的腹主動脈內，以幫助保護動脈瘤免於破裂。 AAA 病例的增加以及對微創手術治療的需求不斷成長正在推動市場對這些覆膜支架的需求。

就最終用戶而言，主動脈覆膜支架市場分為醫院和門診手術中心。由於專業且複雜的科學儀器的存在，預計醫院領域將在 2023 年至 2031 年期間佔據重要的市場佔有率。這些組織僱用了受過現代醫學科學問題教育的訓練有素的工作人員團隊。他們透過為患有各種疾病的患者提供廣泛的醫療服務而發揮著重要作用。因此，醫院是主動脈覆膜支架裝置的主要最終用戶，因為它們提供廣泛的醫療服務，包括 EVAR 和胸主動脈血管內修復 (TEVAR) 等侵入性手術。

主動脈覆膜支架市場：地理概況

全球近距離治療設備市場報告的範圍涵蓋北美（美國、加拿大和墨西哥）、歐洲（德國、法國、義大利、英國、西班牙和歐洲其他地區）、亞太地區（中國、日本、印度）、澳洲、韓國以及亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國以及中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地區）。 2023年，北美佔據主動脈覆膜支架主要市場佔有率，其次是歐洲；亞太地區的市場在預測期內以最高的複合年成長率成長。該地區主動脈覆膜支架市場的成長歸因於該地區主動脈瘤發生率及其危險因子的上升。

歐洲
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 歐洲其他地區
亞太
- 澳洲
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地區

第 10 章：產業格局

併購
協議、合作、合資企業
新產品發布
擴張和其他策略發展

第 11 章：競爭格局

關鍵參與者的熱圖分析
公司定位與專注

第 12 章：主動脈覆膜支架市場 - 主要公司概況

Endologix Inc
Terumo Corporation
Radcliffe Medical Media
MicroPort Scientific Corporation
Corcym
LeMaitre Vascular, Inc
W. L. Gore & Associates, Inc
JOTEC GmbH
Medtronic

第 13 章：附錄

簡介目錄

Product Code: TIPHE100000878

The aortic stent grafts market is projected to grow from US$ 2.49 billion in 2023 to US$ 4.03 billion by 2031; the market is estimated to record a CAGR of 6.2% during 2023-2031.

Key factors driving the market growth are the increasing incidence of aortic aneurysms and the rising demand for minimally invasive procedures such as endovascular repairs. However, product recalls initiated by the market players hinder the market growth. Furthermore, technological advancements and strategic activities by the manufacturers are expected to bring new aortic stent grafts market trends in the coming years.

Market Drivers and Restraints of the Aortic Stent Grafts Market

The rising prevalence of aortic aneurysms contributes to the aortic stent grafts market growth. According to the article published by Elsevier in March 2021, abdominal aortic aneurysms (AAA) are found in 2% to 8% of people in developed countries. It can progress to life-threatening rupture, with mortality rates as high as 80% if left untreated. Aortic stent grafts are a critical component of endovascular repair of aortic aneurysms. According to the AAA standards report 2020 to 2021 published by the National Health Service (NHS) AAA screening program in April 2022, ~210,800 men were offered screening, during which 1,542 aneurysms cases were detected. Among the patients detected with aneurysms, 88.8% who were suitable for elective repair underwent the procedure. Obesity, smoking, and a sedentary lifestyle are among the risk factors for this cardiovascular condition. The geriatric population is more vulnerable to developing cardiovascular diseases, including aortic aneurysms, owing to which they often require endovascular aneurysm repair (EVAR) surgeries. Aortic stent grafts are majorly used in these surgeries owing to their advantages, such as reduced hospital and ICU stay and blood loss, over traditional open repair surgeries. Therefore, the high number of surgeries for aortic aneurysms drives the aortic stent grafts market growth.

However, increasing product recalls in the aortic stent graft market have raised concerns among healthcare providers and patients. These recalls can be due to design flaws, manufacturing defects, or inadequate safety standards. A few product recalls by the key players in the aortic stent graft market are mentioned below:

In May 2023, Terumo Aortic issued a voluntary recall of specific lots of the Terumo Aortic TREO Abdominal Stent-Graft Systems due to the potential issue of having an incorrectly sized graft.

In February 2021, Medtronic recalled its unused Valiant Navion thoracic stent graft system due to a risk of stent fractures and Type III endoleaks.

In May 2020, Endologix Inc. announced a recall of its Ovation iX product due to the risk of liquid polymer leaks during implantation. The company stated that the root cause of most polymer leaks was a material weakness during manufacturing.

As a result of product recalls, trust in certain brands and products may diminish, leading to a potential decline in demand for aortic valve replacement devices. In addition, patients and medical professionals may become extra cautious when considering these devices, preferring to opt for alternatives or delaying procedures. Thus, an increase in product recalls hampers the aortic stent grafts market growth.

Aortic Stent Grafts Market: Segmental Overview

The aortic stent grafts market is segmented on the basis of product and end user. By product, the market is bifurcated into abdominal aortic stent grafts and thoracic aortic stent grafts. The abdominal aortic stent graft segment held a larger market share in 2023. Abdominal aortic stent grafts are medical devices utilized in EVAR to treat aortic aneurysms of the abdomen. This stent graft is implanted inside the abdominal aorta of the patient to help protect the aneurysm from rupturing. Increasing cases of AAA and the rising demand for minimally invasive surgery for treatment are boosting the demand for these stent-grafts in the market.

In terms of end users, the aortic stent grafts market is segmented into hospitals and ambulatory surgical centers. The hospital segment is anticipated to hold a significant market share during 2023-2031, owing to the presence of specialized and complex scientific instruments. These organizations employ teams of trained staff educated in the problems of modern medical science. They serve a significant role by providing extensive medical services to patients with various diseases. Therefore, hospitals are the primary end users of aortic stent graft devices as they offer a wide range of medical services, including invasive procedures such as EVAR and thoracic endovascular aortic repair (TEVAR).

Aortic Stent Grafts Market: Geographical Overview

The scope of the global brachytherapy devices market report entails North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America held a major aortic stent grafts market share in 2023, followed by Europe; the market in the Asia Pacific region is growing with the highest CAGR during the forecast period. The growth of the aortic stent grafts market in this region is attributed to the rising incidence of aortic aneurysm and its risk factors in the region.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Aortic Stent Grafts Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Aortic Stent Grafts Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Aortic Stent Grafts Market - Global Market Analysis

6.1 Aortic Stent Grafts - Global Market Overview
6.2 Aortic Stent Grafts - Global Market and Forecast to 2031

7. Aortic Stent Grafts Market - Revenue Analysis (USD Million) - By Product, 2021-2031

7.1 Overview
7.2 Abdominal Aortic Stent Grafts
7.3 Thoracic Aortic Stent Grafts

8. Aortic Stent Grafts Market - Revenue Analysis (USD Million) - By End User, 2021-2031

8.1 Overview
8.2 Hospitals
8.3 Ambulatory Surgical Centers

9. Aortic Stent Grafts Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

9.1 North America
- 9.1.1 North America Aortic Stent Grafts Market Overview
- 9.1.2 North America Aortic Stent Grafts Market Revenue and Forecasts to 2031
- 9.1.3 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By Product
- 9.1.4 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By End User
- 9.1.5 North America Aortic Stent Grafts Market Revenue and Forecasts and Analysis - By Countries
  - 9.1.5.1 United States Aortic Stent Grafts Market
    - 9.1.5.1.1 United States Aortic Stent Grafts Market, by Product
    - 9.1.5.1.2 United States Aortic Stent Grafts Market, by End User
  - 9.1.5.2 Canada Aortic Stent Grafts Market
    - 9.1.5.2.1 Canada Aortic Stent Grafts Market, by Product
    - 9.1.5.2.2 Canada Aortic Stent Grafts Market, by End User
  - 9.1.5.3 Mexico Aortic Stent Grafts Market
    - 9.1.5.3.1 Mexico Aortic Stent Grafts Market, by Product
    - 9.1.5.3.2 Mexico Aortic Stent Grafts Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

9.2 Europe
- 9.2.1 Germany
- 9.2.2 France
- 9.2.3 Italy
- 9.2.4 Spain
- 9.2.5 United Kingdom
- 9.2.6 Rest of Europe
9.3 Asia-Pacific
- 9.3.1 Australia
- 9.3.2 China
- 9.3.3 India
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
9.4 Middle East and Africa
- 9.4.1 South Africa
- 9.4.2 Saudi Arabia
- 9.4.3 U.A.E
- 9.4.4 Rest of Middle East and Africa
9.5 South and Central America
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Rest of South and Central America

10. Industry Landscape

10.1 Mergers and Acquisitions
10.2 Agreements, Collaborations, Joint Ventures
10.3 New Product Launches
10.4 Expansions and Other Strategic Developments

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players
11.2 Company Positioning and Concentration

12. Aortic Stent Grafts Market - Key Company Profiles

12.1 Endologix Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments

Note - Similar information would be provided for below list of companies